Related references
Note: Only part of the references are listed.Downregulation of HLA-ABC expression through promoter hypermethylation and downmodulation of MIC-A/B surface expression in LMP2A-positive epithelial carcinoma cell lines
Shweta Singh et al.
SCIENTIFIC REPORTS (2020)
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
Yu-Pei Chen et al.
CELL RESEARCH (2020)
Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma
Shanzhao Jin et al.
CELL RESEARCH (2020)
The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
Shaodong Hong et al.
NATURE COMMUNICATIONS (2019)
Latency and lytic replication in Epstein-Barr virus-associated oncogenesis
Christian Muenz
NATURE REVIEWS MICROBIOLOGY (2019)
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
Stefanie Maurer et al.
ONCOIMMUNOLOGY (2018)
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B. Y. Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Role of platelets and platelet receptors in cancer metastasis
Martin Schlesinger
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Vasculogenic mimicry formation in EBV-associated epithelial malignancies
Tong Xiang et al.
NATURE COMMUNICATIONS (2018)
The Microenvironment in Epstein-Barr Virus-Associated Malignancies
Geok Wee Tan et al.
PATHOGENS (2018)
Epstein-Barr virus infection and nasopharyngeal carcinoma
Sai Wah Tsao et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Regulation of Murine Natural Killer Cell Development
Wilford Goh et al.
FRONTIERS IN IMMUNOLOGY (2017)
Epstein-Barr virus: more than 50 years old and still providing surprises
Lawrence S. Young et al.
NATURE REVIEWS CANCER (2016)
Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma
Wen-Hui Chen et al.
BMC CANCER (2014)
Cytotoxic T Cell Adoptive Immunotherapy as a Treatment for Nasopharyngeal Carcinoma
Viviana P. Lutzky et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis
Edward C. Stack et al.
METHODS (2014)
Thrombocytosis is a significant indictor of hypercoagulability, prognosis and recurrence in gastric cancer
Changyuan Hu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis
Yoshinori Ito et al.
PEDIATRIC BLOOD & CANCER (2013)
Tissue Factor Pathway Inhibitor Attenuates the Progression of Malignant Pleural Mesothelioma in Nude Mice
LaTerrica Williams et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer
Jian-Guo Wang et al.
BLOOD (2012)
Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
Theresa Placke et al.
CANCER RESEARCH (2012)
The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
Simon Jochum et al.
PLOS PATHOGENS (2012)
The wolf in sheep's clothing Platelet-derived pseudo self impairs cancer cell missing self recognition by NK cells
Theresa Placke et al.
ONCOIMMUNOLOGY (2012)
Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes
Jesse W. Rowley et al.
BLOOD (2011)
IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway
Hyunkeun Song et al.
IMMUNOLOGY LETTERS (2011)
Epstein-Barr Virus-Encoded LMP2A Induces an Epithelial-Mesenchymal Transition and Increases the Number of Side Population Stem-like Cancer Cells in Nasopharyngeal Carcinoma
Qing-Li Kong et al.
PLOS PATHOGENS (2010)
Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
Hans-Georg Kopp et al.
CANCER RESEARCH (2009)
Diverse Herpesvirus MicroRNAs Target the Stress-induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells
Daphna Nachmani et al.
CELL HOST & MICROBE (2009)
Epstein-Barr Virus LF2: an Antagonist to Type I Interferon
Liguo Wu et al.
JOURNAL OF VIROLOGY (2009)
Alternatively spliced tissue factor induces angiogenesis through integrin ligation
Y. W. van den Berg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice
Henri H. Versteeg et al.
CANCER RESEARCH (2008)
EBV MicroRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3
Tianli Xia et al.
CANCER RESEARCH (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
Andrew D. Hislop et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion
Martin Rowe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A guide to murine platelet structure, function, assays, and genetic alterations
M. Jirouskova et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Formation of tissue factor-factorVIIa-factor Xa complex prevents apoptosis in human breast cancer cells
Xiaofeng Jiang et al.
THROMBOSIS AND HAEMOSTASIS (2006)
Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection
H Kimura et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway
T Portis et al.
ONCOGENE (2004)
Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma
N Heussinger et al.
JOURNAL OF PATHOLOGY (2004)
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition
ME Ressing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
